AGENUS INC | Business Contracts

Form of 2022 B Warrant (Filed With SEC on December 2, 2022)

Consulting Agreement dated January 1, 2022 between Agenus Inc. and Jennifer Buell (Filed With SEC on May 10, 2022)

License, Development and Commercialization Agreement, dated May 17, 2021, by and between Agenus Inc. and Bristol Myers Squibb Company (Filed With SEC on August 9, 2021)

Office Lease by and between Bay Center Investor LLC and Agenus Inc. dated November 25, 2020 (Filed With SEC on November 25, 2020)

License and Collaboration Agreement, dated as of June 20, 2020, by and between Agenus Inc. and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)

Description of Securities (Filed With SEC on March 16, 2020)

Form of 2022 A Warrant (Filed With SEC on December 2, 2022)

Executive Employment Agreement dated October 27, 2020 between Agenus Inc. and Steven ODay (Filed With SEC on May 10, 2022)

Amendment to Consulting Agreement between Agenus Inc. and Evan Kearns, dated January 31, 2022 (Filed With SEC on March 1, 2022)

Consulting Agreement dated April 30, 2021 between Agenus Inc. and Evan Kearns (Filed With SEC on March 1, 2022)

Amendment to Consulting Agreement between Agenus Inc. and Brian Corvese, dated January 1, 2022 (Filed With SEC on March 1, 2022)

Amendment to the Agenus Inc. 2019 Equity Incentive Plan, dated February 2, 2022 (Filed With SEC on March 1, 2022)

Amendment No. 1 to Royalty Purchase Agreement, dated June 22, 2021, by and among Antigenics LLC, Healthcare Royalty Partners III, L.P. and certain of its affiliates (Filed With SEC on August 9, 2021)

Executive Employment Agreement dated November 6, 2020, by and between Agenus Inc. and Evan Kearns (Filed With SEC on November 9, 2020)

Stock Purchase Agreement, dated as of June 20, 2020, by and among Agenus Inc., Betta Investment (Hong Kong) Limited, and Betta Pharmaceuticals Co., Ltd (Filed With SEC on August 10, 2020)

Consulting Agreement dated January 1, 2020 between Agenus Inc. and Brian Corvese (Filed With SEC on May 11, 2020)

Form of Warrant under the Amended and Restated Note Purchase Agreement dated as of February 18, 2020 (Filed With SEC on March 16, 2020)

Amendment to Notes and Warrants dated as of February 18, 2020 by and among Agenus Inc. and the Investors listed therein (Filed With SEC on March 16, 2020)

Form of Restricted Stock Unit Award Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Form of Non-Qualified Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Form of Incentive Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on March 16, 2020)

Executive Employment Agreement dated August 8, 2019, by and between Agenus Inc. and Dr. Jennifer Buell (Filed With SEC on August 9, 2019)

Agenus Inc. 2019 Equity Incentive Plan (Filed With SEC on June 24, 2019)

Option and License Agreement (AGEN2373) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

Option and License Agreement (AGEN1223) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

License Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

Stock Purchase Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)

AGENUS INC (27)